BillionToOne, Inc. Share Price & Technical Analysis
BLLN · $102.4 (+8.43%)
Healthcare / Diagnostics & Research
$102.4
+8.43%
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and…
Price chart
Seasonality
Jun has 1 positive and 0 negative years (last 2 years shown)
30% return in 2026, -6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -1% | -8% | 7% | -3% | 31% | 4% | – | – | – | – | – | – | 30% |
| 25 | – | – | – | – | – | – | – | – | – | – | 30% | -37% | -6% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.46B
P/E ratio
179.54
52W high
$138.7
52W low
$61.96
Volume
6,76,369
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is BillionToOne, Inc. share price today?
- BillionToOne, Inc. (BLLN) last traded around $102.4 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BLLN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BLLN. Download the app for real-time alerts.
- How can I analyze BillionToOne, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.